Comorbidity of premenstrual syndrome and premenstrual dysphoric disorder with other psychiatric conditions

The Premenstrual Syndromes: PMS and PMDD

Volumn , Issue , 2007, Pages 49-54

  Yonkers, Kimberly A ^a   McCunn, Kara Lynn ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77955073192     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (71)

1. Borenstein J, Dean B, Endicott J et al. Health and economic impact of the premenstrual syndrome. J Reprod Med 2003; 48:515-24.
2. Deuster P, Adera T, South-Paul J. Biological, social, and behavioral factors associated with premenstrual syndrome. Arch Fam Med 1999; 8:122-8.
3. Wood C, Larsen L, Williams R. Menstrual characteristics of 2343 women attending the Shepard Foundation. Aust N Z J Obstet Gynaecol 1979; 19:107-10.
4. Rivera-Tovar AD, Frank E. Late luteal phase dysphoric disorder in young women. Am J Psychiatry 1990; 147:1634-6.
5. Soares C, Cohen L, Otto M, Harlow B. Characteristics of women with premenstrual dysphoric disorder (PMDD) who did or did not report history of depression: a preliminary report from the Harvard Study of Moods and Cycles. J Womens Health Gend Based Med 2001; 10:873-8.
6. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn - DSM-IV. Washington DC:American Psychiatric Association; 1994.
7. ACOG. ACOG issues guidelines on diagnosis and treatment of PMS. 2003.
8. Rubinow DR, Roy-Byrne P, Hoban MC, Gold PW, Post RM. Prospective assessment of menstrually related mood disorders. Am J Psychiatry 1984; 141(5):684-6.
9. Rubinow DR, Roy-Byrne PP. Premenstrual syndromes: overviews from a methodologic perspective. Am J Psychiatry 1984; 141:163-72.
10. Yonkers KA, White K. Premenstrual exacerbation of depression:one process of two? J Clin Psychiatry 1992; 53:289-92.
11. Kessler R. Epidemiology of women and depression. J Affect Disord 2003; 74(1):5-13.
12. Kessler RC, McGonagle KA, Swartz M et al. Sex and depression in the National Comorbidity Survey. I: Lifetime prevalence, chronicity and recurrence. J Affect Disord 1993; 29:85-96.
13. Kessler R, Mcgonagle K, Zhao S et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994; 51:8-19.
14. Hasin DS, Goodwin RD, Stinson FS, Grant BF. Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions. Arch Gen Psychiatry 2005; 62(10):1097-106.
15. Yonkers K. The association between premenstrual dysphoric disorder and other mood disorders. J Clin Psychiatry 1997; 58(Suppl 0).
16. Kim D, Gyulai L, Freeman E et al. Premenstrual dysphoric disorder and psychiatric comorbidity. Arch Womens Ment Health 2004; 7:37-47.
17. Breaux C, Hartlage S, Gehlert S. Relationships of premenstrual dysphoric disorder to major depression and anxiety disorders: a re-examination. J Psychosom Obstet Gynecol 2000; 21:17-24.
18. Critchlow D, Bond AJ, Wingrove J. Mood disorder history and personality assessment in premenstrual dysphoric disorder. J Clin Psychiatry 2001; 62:688-93.
19. Freeman EW, Rickels K, Sondheimer SJ et al. Nefazodone in the treatment of premenstrual syndrome: a preliminary study. J Clin Psychopharmacol 1994; 14(3):180-6.
20. Freeman EW, Rickels K, Sondheimer SJ, Polansky M. A doubleblind trial of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome. JAMA 1995; 274:51-7.
21. Harrison WM, Endicott J, Nee J, Glick H, Rabkin JG. Characteristics of women seeking treatment for premenstrual syndrome. Psychosomatics 1989; 30:405-11.
22. Harrison WM, Endicott J, Nee J. Treatment of premenstrual dysphoria with alprazolam. A controlled study. Arch Gen Psychiatry 1990; 47:270-5.
23. Pearlstein TB, Frank E, Rivera-Tovar A et al. Prevalence of axis I and axis II disorders in women with late luteal phase dysphoric disorder. J Affect Disord 1990; 20:129-34.
24. Pearlstein TB, Stone AB. Long-term fluoxetine treatment of late luteal phase dysphoric disorder. J Clin Psychiatry 1994; 55:332-5.
25. Yonkers KA, Halbreich U, Freeman E et al. Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. JAMA 1997; 278:983-8.
26. Dejong R, Rubinow DR, Roy-Byrne P et al. Premenstrual mood disorder and psychiatric illness. Am J Psychiatry 1985; 142(11):1359-61.
27. West C. The characteristics of 100 women presenting to a gynecological clinic with premenstrual complaints. Acta Obstet Gynecol Scand 1989; 68:743-7.
28. De Ronchi D, Muro A, Marziani A, Rucci P. Personality disorders and depressive symptoms in late luteal phase dysphoric disorder. Pyschother Psychosom 2000; 69:27-34.
29. Coppen A. The prevalence of menstrual disorders in psychiatric patients. Br J Psychiatry 1965; III:155-67.
30. Diamond SB, Rubinstein AA, Dunner DL, Fieve RR. Menstrual problems in women with primary affective illness. Compr Psychiatry 1976; 17:541-8.
31. Halbreich U, Endicott J. Relationship of dysphoric premenstrual changes to depressive disorder. Acta Psychiatr Scand 1985; 71:331-8.
32. Kashiwagi T, Mcclure JN, Wetzel RD. Premenstrual affective syndrome and psychiatric disorder. Dis Nerv Syst 1976; 37:116-19.
33. Kornstein S, Harvey A, Rush A et al. Self-reported premenstrual exacerbation of depressive symptoms in patients seeking treatment for major depression. Psychol Med 2005; 35:683-92.
34. Praschak-Rieder N, Willeit M, Neumeister A et al. Prevalence of premenstrual dysphoric disorder in female patients with seasonal affective disorder. J Affect Disord 2001; 63:239-42.
35. Hartlage S, Brandenburg D, Kravitz H. Premenstrual exacerbation of depressive disorders in a community-based sample in the United States. Psychosom Med 2004; 66:698-706.
36. Graze KK, Nee J, Endicott J. Premenstrual depression predicts future major depressive disorder. Acta Psychiatr Scand 1990; 81:201-5.
37. Schuckit M, Daly V, Herrman G, Hineman S. Premenstrual symptoms and depression in a university population. Dis Nerv Syst 1975; 37:516-17.
38. Wetzel RD, Reich T, Mcclure JN, Wald JA. Premenstrual affective syndrome and affective disorder. Br J Psychiatry 1975; 127:219-21.
39. Bancroft J, Rennie D, Warner P. Vulnerability to perimenstrual mood change: the relevance of a past history of depressive disorder. Psychosom Med 1994; 56:225-31.
40. Halbreich U. Premenstrual dysphoric disorders: a diversified cluster of vulnerability traits to depression. Acta Psychiatr Scand 1997; 95:169-76.
41. Mortola JF, Liu JH, Gillin JC et al. Pulsatile rhythms of adrenocorticotropin (ACTH) and cortisol in women with endogenous depression: evidence for increased ACTH pulse frequency. J Clin Endocrinol Metab 1987; 65:962-8.
42. Halbreich U, Petty F, Yonkers K et al. Low plasma _-aminobutyric acid levels during the late luteal phase of women with premenstrual dysphoric disorder. Am J Psychiatry 1996; 153:718-20.
43. Price WA, Dimarzio LR. Premenstrual tension syndrome in rapidcycling bipolar affective disorder. J Clin Psychiatry 1986; 47(8):415-17.
44. Roy-Byrne PP, Rubinow DR, Hoban MC et al. Premenstrual changes: a comparison of five populations. Psychiatry Res 1986; 17:77-85.
45. Leibenluft E, Ashman SB, Feldman-Naim S, Yonkers KA. Lack of relationship between menstrual cycle phase and mood in a sample of women with rapid cycling bipolar disorder. Biol Psychiatry 1999; 46(4):577-80.
46. Kessler RC, Berglund P, Demler O et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication [see comment] [erratum appears in Arch Gen Psychiatry 2005; 62(7):768 Note
47. Merikangas, Kathleen R [added]]. Arch Gen Psychiatry 2005; 62(6):593-602.
48. Chandraiah S, Levenson J, Collins J. Sexual dysfunction, social maladjustment, and psychiatric disorders in women seeking treatment in a premenstrual syndrome clinic. Int J Psychiatry Med 1991; 21(2):189-204.
49. Stout AL, Steege JF, Blazer DG, George LK. Comparison of lifetime psychiatric diagnoses in Premenstrual Syndrome Clinic and community samples. J Nerv Ment Dis 1986; 174:517-22.
50. Fava M, Pedrazzi F, Guaraldi GP et al. Comorbid anxiety and depression among patients with late luteal phase dysphoric disorder. J Anx Disord 1992; 6:325-35.
51. Williams KE, Koran LM. Obsessive-compulsive disorder in pregnancy, the puerperium and the premenstruum. J Clin Psychiatry 1997; 58(7):330-4.
52. Labad J, Menchon JM, Alonso P et al. Female reproductive cycle and obsessive-compulsive disorder. J Clin Psychiatry 2005; 66(4):428-35.
53. Vulink NC, Denys D, Bus L, Westenberg HG. Female hormones affect symptom severity in obsessive-compulsive disorder. Int Clin Psychopharmacol 2006; 21(3):171-5.
54. Cameron OG, Kuttesch D, McPhee K, Curtis GC. Menstrual fluctuation in the symptoms of panic anxiety. J Affect Disord 1988; 15:169-74.
55. Cook BL, Noyes R, Garvey MJ et al. Anxiety and the menstrual cycle in panic disorder. J Affect Disord 1990; 19:221-6.
56. Stein MB, Schmidt PJ, Rubinow DR, Uhde TW. Panic disorder and the menstrual cycle: panic disorder patients, healthy control subjects, and patients with premenstrual syndrome. Am J Psychiatry 1989; 146(10):1299-303.
57. Kaspi S, Otto M, Pollack M et al. Premenstrual exacerbation of symptoms in women with panic disorder. J Anx Disord 1994; 8(2):131-8.
58. Vickers K, McNally RJ. Is premenstrual dysphoria a variant of panic disorder? A review. Clin Psychol Rev 2004; 24:933-56.
59. Facchinetti F, Romano G, Fava M, Genassani AR. Lactate infusion induces panic attacks in patients with premenstrual syndrome. Psychosom Med 1992; 54:288-96.
60. Sandberg D, Endicott J, Harrison W et al. Sodium lactate infusion in late luteal phase dysphoric disorder. Psychiatry Res 1993; 46:79-88.
61. Schwartz GE, Goetz RR, Klein DF et al. Tidal volume of respiration and ‘sighing’ as indicators of breathing irregularities in panic disorder patients. Anxiety 1996; 2(3):145-8.
62. Harrison W, Sandberg D, Gorman J et al. Provocation of panic with carbon dioxide inhalation in patients with premenstrual dysphoria. Psychiatry Res 1989; 27:183-92.
63. Le Melledo JM, Bradwejn J, Koszycki D, Bichet D. Premenstrual dysphoric disorder and response to cholecystokinin-tetrapeptide. Arch Gen Psychiatry 1995; 52:605-6.
64. Le Melledo J, Van Driel M, Coupland N et al. Response to flumazenil in women with premenstrual dysphoric disorder. Am J Psychiatry 2000; 157(6):821-3.
65. McLeod DR, Hoehn-Saric R, Foster GV, Hipsley PA. The influence of premenstrual syndrome on ratings of anxiety in women with generalized anxiety disorder. Acta Psychiatr Scand 1993; 88:248-51.
66. Severino SK, Yonkers KA. A literature review of psychotic symptoms associated with the premenstruum. Psychosomatics 1993; 34(4):299-306.
67. Kranidiotis LS, Rajendran JP. Goserelin for menstrual psychosis J Obstet Gynaecol 2006;26(2):183.
68. Harris AH. Menstrually related symptom changes in women with schizophrenia. Schizophrenia Res 1997; 27:93-9.
69. Choi SH, Kang SB, Joe SH. Changes in premenstrual symptoms in women with schizophrenia: a prospective study. Psychosom Med 2001; 63:822-9.
70. Bergemann N, Parzer P, Nagl I et al. Acute psychiatric admission and menstrual cycle phase in women with schizophrenia. Arch Womens Ment Health 2002; 5(3):119-26.
71. Lande RG, Karamchandani V. Chronic mental illness and the menstrual cycle. J Am Osteopath Assoc 2002; 102(12):655-9.